A randomised phase II/III study of Docetaxel plus Prednisolone vs. Docetaxel plus Prednisolone plus Zoledronic acid vs. Docetaxel plus Prednisolone plus Strontium-89 vs. Docetaxel plus Prednisolone plus Zoledronic acid plus Strontium-89 in Hormone Refractory Prostate cancer metastatic to bone.
If your are a Health Professional and would like access to the section of the site for Health Professionals please email your interest to the trial co-ordinator, Ann Pope.
Please ensure that your site is using the correct version of the Trapeze Protocol. Version 10 is the current version. Links to versions 8 and 10 (NB. Version 9 was not implemented) are available for download in the Health Professional section of the site.
Trial now closed for recruitment.
TRIAL NOW CLOSED TO RECRUITMENT
THANK YOU FOR RECRUITING 757 PATIENTS
NEW PROTOCOL RELEASED
Please visit the investigators home page for further information.
The Clinical Trials Unit at the Cancer Research UK, Institute of Cancer Studies stands comfortably between the Pan Birmingham network of Hospitals that serve a population of over 5,000,000 people and a large basic science research group of over 200 researchers situated at the Institute of Cancer Studies.